First Time Loading...

Avacta Group PLC
LSE:AVCT

Watchlist Manager
Avacta Group PLC Logo
Avacta Group PLC
LSE:AVCT
Watchlist
Price: 48.5 GBX 1.04% Market Closed
Updated: Apr 20, 2024

Intrinsic Value

AVCT's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

Avacta Group Plc engages in the provision of Affimer reagents for licensing into third-party research and diagnostic products, and creates new Affimer medicines for development in-house and licensing... [ Read More ]

The intrinsic value of one AVCT stock under the Base Case scenario is 63.54 GBX. Compared to the current market price of 48.5 GBX, Avacta Group PLC is Undervalued by 24%.

Key Points:
AVCT Intrinsic Value
Base Case
63.54 GBX
Undervaluation 24%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Avacta Group PLC

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling AVCT stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Avacta Group PLC

Provide an overview of the primary business activities
of Avacta Group PLC.

What unique competitive advantages
does Avacta Group PLC hold over its rivals?

What risks and challenges
does Avacta Group PLC face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Avacta Group PLC.

Provide P/S
for Avacta Group PLC.

Provide P/E
for Avacta Group PLC.

Provide P/OCF
for Avacta Group PLC.

Provide P/FCFE
for Avacta Group PLC.

Provide P/B
for Avacta Group PLC.

Provide EV/S
for Avacta Group PLC.

Provide EV/GP
for Avacta Group PLC.

Provide EV/EBITDA
for Avacta Group PLC.

Provide EV/EBIT
for Avacta Group PLC.

Provide EV/OCF
for Avacta Group PLC.

Provide EV/FCFF
for Avacta Group PLC.

Provide EV/IC
for Avacta Group PLC.

Show me price targets
for Avacta Group PLC made by professional analysts.

What are the Revenue projections
for Avacta Group PLC?

How accurate were the past Revenue estimates
for Avacta Group PLC?

What are the Net Income projections
for Avacta Group PLC?

How accurate were the past Net Income estimates
for Avacta Group PLC?

What are the EPS projections
for Avacta Group PLC?

How accurate were the past EPS estimates
for Avacta Group PLC?

What are the EBIT projections
for Avacta Group PLC?

How accurate were the past EBIT estimates
for Avacta Group PLC?

Compare the revenue forecasts
for Avacta Group PLC with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Avacta Group PLC and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Avacta Group PLC against its competitors.

Analyze the profit margins
(gross, operating, and net) of Avacta Group PLC compared to its peers.

Compare the P/E ratios
of Avacta Group PLC against its peers.

Discuss the investment returns and shareholder value creation
comparing Avacta Group PLC with its peers.

Analyze the financial leverage
of Avacta Group PLC compared to its main competitors.

Show all profitability ratios
for Avacta Group PLC.

Provide ROE
for Avacta Group PLC.

Provide ROA
for Avacta Group PLC.

Provide ROIC
for Avacta Group PLC.

Provide ROCE
for Avacta Group PLC.

Provide Gross Margin
for Avacta Group PLC.

Provide Operating Margin
for Avacta Group PLC.

Provide Net Margin
for Avacta Group PLC.

Provide FCF Margin
for Avacta Group PLC.

Show all solvency ratios
for Avacta Group PLC.

Provide D/E Ratio
for Avacta Group PLC.

Provide D/A Ratio
for Avacta Group PLC.

Provide Interest Coverage Ratio
for Avacta Group PLC.

Provide Altman Z-Score Ratio
for Avacta Group PLC.

Provide Quick Ratio
for Avacta Group PLC.

Provide Current Ratio
for Avacta Group PLC.

Provide Cash Ratio
for Avacta Group PLC.

What is the historical Revenue growth
over the last 5 years for Avacta Group PLC?

What is the historical Net Income growth
over the last 5 years for Avacta Group PLC?

What is the current Free Cash Flow
of Avacta Group PLC?

Financials

Balance Sheet Decomposition
Avacta Group PLC

Current Assets 40.8m
Cash & Short-Term Investments 26m
Receivables 11.7m
Other Current Assets 3.1m
Non-Current Assets 47m
Long-Term Investments 4.5m
PP&E 9m
Intangibles 33.5m
Current Liabilities 57.1m
Accounts Payable 10.8m
Short-Term Debt 44.6m
Other Current Liabilities 1.7m
Non-Current Liabilities 7.9m
Long-Term Debt 4.9m
Other Non-Current Liabilities 3m
Efficiency

Earnings Waterfall
Avacta Group PLC

Revenue
16m GBP
Cost of Revenue
-7.3m GBP
Gross Profit
8.7m GBP
Operating Expenses
-36.4m GBP
Operating Income
-27.7m GBP
Other Expenses
-15.1m GBP
Net Income
-42.8m GBP

Free Cash Flow Analysis
Avacta Group PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

AVCT Profitability Score
Profitability Due Diligence

Avacta Group PLC's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
Exceptional Revenue Growth Forecast
Exceptional 1-Year Revenue Growth
33/100
Profitability
Score

Avacta Group PLC's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

AVCT Solvency Score
Solvency Due Diligence

Avacta Group PLC's solvency score is 30/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Positive Net Debt
Short-Term Solvency
High D/E
30/100
Solvency
Score

Avacta Group PLC's solvency score is 30/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

AVCT Price Targets Summary
Avacta Group PLC

Wall Street analysts forecast AVCT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AVCT is 94.18 GBX with a low forecast of 70.7 GBX and a high forecast of 110.25 GBX.

Lowest
Price Target
70.7 GBX
46% Upside
Average
Price Target
94.18 GBX
94% Upside
Highest
Price Target
110.25 GBX
127% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

AVCT Price
Avacta Group PLC

1M 1M
-8%
6M 6M
-63%
1Y 1Y
-63%
3Y 3Y
-80%
5Y 5Y
+46%
10Y 10Y
-59%
Annual Price Range
48.5
52w Low
48
52w High
159.6
Price Metrics
Average Annual Return 128.69%
Standard Deviation of Annual Returns 287.94%
Max Drawdown -85%
Shares Statistics
Market Capitalization 168.2m GBX
Shares Outstanding 346 710 137
Percentage of Shares Shorted
N/A

AVCT Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Avacta Group PLC Logo
Avacta Group PLC

Country

United Kingdom

Industry

Biotechnology

Market Cap

168.2m GBP

Dividend Yield

0%

Description

Avacta Group Plc engages in the provision of Affimer reagents for licensing into third-party research and diagnostic products, and creates new Affimer medicines for development in-house and licensing to large pharmaceutical companies. The company is headquartered in Wetherby, West Yorkshire. The company went IPO on 2003-09-08. The firm is focused on developing cancer immunotherapies and diagnostics based on its Affimer and prelCISION platforms. The company has two divisions: Therapeutics and Diagnostics. Avacta’s therapeutics division develops cancer immunotherapies combining its platforms: Affimer biotherapeutics and prelCISION tumor targeted chemotherapy. The Affimer platform is a class of biotherapeutic based on a naturally occurring human protein. Avacta's prelCISION targeted chemotherapy platform releases active chemotherapy in the tumor, which limits the systemic exposure that causes damage to healthy tissues, and thereby improves the overall safety and therapeutic potential of these anti-cancer treatments. Avacta’s diagnostics division utilizes its Affimer platform to develop diagnostics and works with partners world-wide to develop Affimer reagents with the objective of establishing royalty-bearing license deals.

Contact

WEST YORKSHIRE
Wetherby
Unit 20, Ash Way
+441904217070.0
https://www.avacta.com/key-information

IPO

2003-09-08

Employees

123

Officers

CEO & Executive Director
Dr. David Alastair Maclaughlin Smith
CFO, Company Secretary & Executive Director
Mr. Tony Gardiner
Head of Research & Development, Interim Chief Medical Officer and Director
Dr. Christina Marie Coughlin B.S., M.D., Ph.D.
Group In-House Counsel
Ms. Emma Wright
Group Communications Director
Mr. Michael Vinegrad
Chief Operating Officer of Diagnostics
Mr. R. Craig Slater FCA
Show More
Chief Scientific Officer of Diagnostics
Dr. Matt Johnson
Chief Scientific Officer of Therapeutics Division
Dr. Fiona McLaughlin FSB, Ph.D.
Chief Commercial Officer of Diagnostics
Mr. David Wilson
Chief Operating Officer of Therapeutics Division
Ms. Karen Harrison
Show Less

See Also

Discover More
What is the Intrinsic Value of one AVCT stock?

The intrinsic value of one AVCT stock under the Base Case scenario is 63.54 GBX.

Is AVCT stock undervalued or overvalued?

Compared to the current market price of 48.5 GBX, Avacta Group PLC is Undervalued by 24%.